GAXtracts manufactures and processes active pharmaceutical ingredients from industrial hemp, with a primary focus on producing CBD and other hemp‑derived products. The company operates a pharmaceutical‑grade facility that partners with farmers to source organic hemp for extraction. Since the start of the COVID‑19 crisis it has also produced a medical‑grade hand sanitizer for hospitals, law enforcement, first responders, and care providers. The business received a $2 million investment to support working capital and to finance new equipment purchases as it scales production. GAXtracts plans to expand into a new facility in Union Point and to create additional jobs in rural Georgia as demand grows. The broader hemp market has grown from roughly $600 million to a forecasted $4 billion by 2022, creating a favorable industry tailwind for the company.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2020